Upstream Bio (UPB) Interest & Investment Income (2023 - 2026)
Upstream Bio's Interest & Investment Income was $2.66 million in Q2 2026, down 40.0% from $4.43 million a year earlier and down 12.9% from the prior quarter.
Powered by 
Analysis
Upstream Bio (UPB) Interest & Investment Income (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Upstream Bio's Interest & Investment Income was $13.47 million through Jun 30, 2026, down 21.5% year-over-year; for FY2025, it was $16.93 million, up 39.7% from FY2024.
- In earlier years, Interest & Investment Income was $12.12 million in FY2024 (+191.1%) and $4.17 million in FY2023.
- The Q2 2026 figure marks the lowest quarterly Interest & Investment Income since Q1 2024.
- Compared with a year earlier, Interest & Investment Income has declined for three straight quarters, with growth averaging 73.8% over the last eight quarters.
- The best year-over-year quarter for Interest & Investment Income over five years was Q1 2025 (growth of 274.6%); the worst was Q2 2026 (a decline of 40.0%).
- Per Business Quant data, UPB's Interest & Investment Income in the three quarters before Q2 2026 was $3.05 million (Q1 2026), $3.65 million (Q4 2025) and $4.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Upstream Bio | 276.05 Mn | 276.05 Mn | -3.29 Mn | 2.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.66 Mn |
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 3.65 Mn |
| Sep 30, 2025 | 4.11 Mn |
| Jun 30, 2025 | 4.43 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 5.08 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.88 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.53 Mn |
API Access
Upstream Bio Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=UPB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "UPB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=UPB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();